COVID-19 vaccine (adenovirus vector) by CanSino Biologics

Adenovirus vector-based COVID-19 vaccine · CanSino Biologics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for COVID-19 vaccine (adenovirus vector) by CanSino Biologics, covering 2023-06-15 to 2023-06-15. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above [Phase 3]

See pricing